CHILDHOOD HODGKIN LYMPHOMA

Clinical trials for CHILDHOOD HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new CHILDHOOD HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for CHILDHOOD HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted drug joins fight against childhood lymphoma

Disease control Ongoing

This large, late-stage trial is testing if adding a targeted drug called brentuximab vedotin to standard chemotherapy works better than chemotherapy alone for children and young adults with newly diagnosed, high-risk Hodgkin lymphoma. The study aims to see if the new combination …

Matched conditions: CHILDHOOD HODGKIN LYMPHOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

CHILDHOOD HODGKIN LYMPHOMA

Get alerted when new CHILDHOOD HODGKIN LYMPHOMA trials appear

Targeted drug joins fight against childhood lymphoma